Exane Derivatives’s Commercial Metals CMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$180K Sell
5,454
-526
-9% -$20.7K 0.1% 186
2022
Q1
$249K Sell
5,980
-1,781
-23% -$66.9K 0.07% 278
2021
Q4
$282K Buy
7,761
+334
+4% +$11.1K 0.07% 271
2021
Q3
$226K Buy
7,427
+1,270
+21% +$40.4K 0.05% 364
2021
Q2
$189K Buy
+6,157
New +$191K 0.04% 416

Other funds holding CMC

Exane Derivatives's CMC Position: Q2 2022 in Review

Exane Derivatives reduced its Commercial Metals (CMC) stake by 8.8% in Q2 2022, selling an estimated $20.7K and leaving 5,454 shares worth $180K. The position accounts for 0.1% of the portfolio, ranked #186.

Exane Derivatives first reported a position in CMC in Q2 2021 and has held it in 5 quarters since. The position peaked at $282K in Q4 2021. 347 funds tracked by Wall St. Rank hold CMC as of Q2 2022.

  • Exane Derivatives held 5,454 shares of Commercial Metals worth $180K as of Q2 2022.
  • Exane Derivatives sold 526 Commercial Metals shares in Q2 2022, an estimated $20.7K.
  • Commercial Metals made up 0.1% of Exane Derivatives's portfolio in Q2 2022, its #186 holding.
  • Exane Derivatives first reported a position in Commercial Metals in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Commercial Metals position peaked at $282K in Q4 2021.
  • 347 funds tracked by Wall St. Rank held Commercial Metals as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.